Grade 4 glioblastomas (GBMs) almost always recur, typically within 6 to 9 months (or 7-10 months) after initial surgery and standard treatment, due to their invasive nature and difficulty in complete removal, with recurrence rates around 90% within two years, though the exact timing varies.
Treatment includes surgery, radiation, and chemotherapy, but even after treatment, GBM almost always grows back in about 9-10 months. This high recurrence rate is due to the invasive nature of the tumor, which infiltrates surrounding brain tissue, making it difficult to remove completely.
Symptoms of glioblastoma recurrence
Common symptoms may include worsening headaches, seizures, cognitive decline, changes in speech and vision, and motor coordination difficulties. If you experience any of these symptoms, it is essential to consult your doctor promptly.
Unfortunately, there is no way to predict if and when a brain tumor will return. According to the Central Brain Tumor Registry of the United States Statistical Report, about 90 percent of patients with glioblastoma will experience a recurrence.
Most GBM recurs in 6 to 9 months and the median OS since recurrence is 3 to 9 months. Despite advancements in clinical trials, there is no uniform standard of care (SOC) for recurrent GBM.
Most cancers that are going to come back will do so in the first 2 years or so after treatment. After 5 years, you are even less likely to get a recurrence. For some types of cancer, after 10 years your doctor might say that you are cured.
(A) Glioblastoma initial neurogenic region contact and contacting or non-contacting recurrence pattern. In total, 84% (95% CI: 0.760–0.901) of recurrent GBMs recurred in contact with neurogenic regions. 36% (95% CI: 0.276–0.459) of recurrent GBMs in contact with neurogenic regions were initially non-contacting.
In this study of 578 patients with primary glioblastoma, 354, 168, 41, and 15 patients underwent 1, 2, 3, or 4 resections, respectively. At last follow-up, the median survival for patients who underwent 1, 2, 3, or 4 resections was 6.8, 15.5, 22.4, and 26.6 months, respectively.
You are likely to have similar symptoms to when you were diagnosed if your brain tumour comes back. Symptoms might include: headaches. seizures (fits)
1. Myth: Cell phones cause glioblastoma. Fact: To date, there is no established link that cell phones cause glioblastoma. Several different studies have failed to find clear evidence of a link between cell phone use and brain cancer.
The cause of most glioblastomas isn't known. Glioblastoma happens when cells in the brain or spinal cord develop changes in their DNA. Healthcare professionals sometimes call these changes mutations or variations. A cell's DNA holds the instructions that tell a cell what to do.
As the tumor expands, it can cause increased pressure within the skull, leading to headaches, nausea, and vomiting. Depending on the exact location, patients may experience neurological deficits such as weakness, speech difficulties, vision changes, or seizures, which are often the presenting symptom.
Glioblastoma patients with blood vitamin D levels greater than 30 ng/mL prior to initiation of chemotherapy and radiation have longer overall survival [65], and those who reported vitamin D use after diagnosis of glioblastoma have been reported to have a survival advantage [45].
After surgery, your healthcare team monitor you closely to look for any signs of complications. They give you medicines to lower the risk of complications. And when you are well enough, they might encourage you to do leg and breathing exercises, and to move around when you are able to.
The average glioblastoma survival time is 12-18 months – only 25% of patients survive more than one year, and only 5% of patients survive more than five years.
A brain surgeon, also known as a neurosurgeon, works to remove as much of the cancer as possible. Glioblastoma often grows into the healthy brain tissue, so it might not be possible to remove all of the cancer cells. Most people have other treatments after surgery to kill the cancer cells that are left.
Fear of Recurrence
Fear of cancer recurrence is a common experience for people living with brain tumors, particularly for patients with glioblastoma. According to an article in the Journal of Clinical Oncology, “most GBM recurs in 6-9 months.”
Brain tumours lack metabolic versatility and are dependent largely on glucose for energy. This contrasts with normal brain tissue that can derive energy from both glucose and ketone bodies.
Research has suggested that surgical resection of a glioblastoma causes the remaining part of the tumor to become more aggressive, resulting in a more rapid rate of growth of malignant cells into the space left by the resection.
Because of this, the tumor usually grows back within six to nine months of initial diagnosis and treatment. Notably, glioblastoma cells can also survive treatment by changing or adapting to their environment. Being able to predict how these changes occur is a crucial step to increasing patient survival.
In the propensity scored matched cohort (n=200), re-resection was associated with a median overall survival of 11.5 months compared to 8.8 months in the no recurrent surgery group, representing a survival benefit of 2.7 months (hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.51-0.96, p=0.002).
Researchers at the University of Michigan in Ann Arbor, Michigan, U.S., have discovered that changes to the diet could be a new avenue to slow down the rapid growth of glioblastoma. Glioblastoma is the most aggressive and deadliest form of brain cancer, affecting 0.59 to 5 per 100,000 individuals worldwide.
Temozolomide Chemotherapy
For glioblastoma, this is typically followed six monthly cycles. Up to 12 cycles may be given for other gliomas. During these six cycles, there is a dose increase from the first cycle to the second, but then the dose stays the same for the remaining cycles.
There are several factors that are believed to increase the risk of glioblastoma, including: Exposure to pesticides, petroleum, synthetic rubber, vinyl chloride and other chemicals. Genetic conditions, such as neurofibromatosis, Li-Fraumeni syndrome and Turcot syndrome that are known to cause tumors.
GBM is known for fast growth rates, it has been described to double in size within around seven weeks. Such tumors can grow at a rate of 1.4 % volume per day, or an equivalent median volume-doubling time of 49.6 days. The average volume at diagnosis is around 17.7 ml (Stensjoen et al., 2015).